Today’s patients have unique cardiologic needs before, during, and after cancer treatment. Chemotherapies, radiation therapy, and targeted therapies can produce acute side effects or lasting adverse consequences on the heart and circulatory system, making the field of cardio-oncology increasingly important in effective patient care. Cardio-Oncology Practice Manual is a comprehensive, portable guide that provides practical approaches to assessment and management of cardiovascular diseases due to the effects of cardiotoxic agents and treatments. Part of the Braunwald family of renowned cardiology references, it clearly presents clinically relevant aspects of this growing field in one quick, practical reference for a wide range of cardio-oncology providers. Covers all major cancer therapies, cardiovascular toxicities, and malignancies in a portable, authoritative guide—ideal for cardiologists, cardio-oncologists, general practitioners, internists, medical oncologists, and hematologists. Offers templated and streamlined content for quick retrieval, with key point summaries for each major section. Presents cardiac disease entities and specific malignant diseases in a succinct overview format addressing important clinical care aspects. Features "Central Illustrations" for each topic that visually summarize the chapter and its specific content including algorithms for management of cardiovascular toxicities and one-view overviews of malignancies. Includes a comprehensive drug guide that provides quick reference to drugs prescribed for cancers with therapeutic indications, manifestations and mechanisms of cardiotoxicity, their risk factors, and risk reduction strategies. Brings you up to date with new immune therapies, including immune checkpoint inhibitors and CAR T-cell therapies
Enrich Your eBook Reading Experience Read directly on your preferred device(s),such as computer, tablet, or smartphone. Easily convert to audiobook,powering your content with natural language text-to-speech.
This book takes a holistic view of the treatment of cardio-oncology patients, from evaluating those at high risk of developing cardio-toxicity, guidance for monitoring and managing patients during therapy to cardiac care of cancer survivors ...
More than 700 questions and answers, derived from and keyed to the 12th Edition of Braunwald’s Heart Disease, provide a quick yet thorough review of essential content for contemporary cardiology practice.
Contains guidelines and appropriate use documents to provide appropriate context for clinicians. Features hundreds of high-quality figures including multimodal cardiac imaging studies, anatomic illustrations, and graphs.
Authoritative, portable, and up to date, Opie’s Cardiovascular Drugs, 9th Edition, is the definitive reference for quick access to frequently used drugs in all phases of care for cardiac patients.
Challenges for the treatment of valvular heart disease include the growing need for effective yet less invasive interventions and therapies to treat these progressive conditions.
Sharma N, Howlett J. Current state of cardiac amyloidosis. ... Rutakingirwa M, Ziegler JL, Newton R, Freers J. Poverty and eosinophilia are risk factors for endomyocardial fibrosis ... Gallagher J, McDonald K, Ledwidge M, Watson CJ.
Complemented by: Braunwald's heart disease.
The third edition of Hypertension: A Companion to Braunwald's Heart Disease, by Drs. George L. Bakris and Matthew Sorrentino, focuses on every aspect of managing and treating patients who suffer from hypertensive disorders.
In print, more than 800 review questions - derived from the 9th Edition of Braunwald's Heart Disease - test your knowledge of all essential concepts in cardiology today.